Renal cell carcinoma

Common Name(s)

Renal cell carcinoma

Renal cell carcinoma (RCC) is one of the most common types of kidney cancers seen in adults. RCC occurs more often in men between the ages of 50 to 70. The kidneys help get rid of waste in the body. There are small tubes in the kidneys that help filter waste from the blood and help make urine. RCC occurs when cells start growing uncontrollably in the lining of these small tubes. Symptoms may not appear in the early stages of renal cell carcinoma, which is why renal cell carcinoma is normally advanced when found. Later symptoms may include blood in urine, a lump in the abdomen, weight loss, anemia, and loss of appetite. If untreated, it may spread to the lymph nodes, lungs, liver, adrenal glands, brain, or bones.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Renal cell carcinoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Renal cell carcinoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Renal cell carcinoma" returned 4371 free, full-text research articles on human participants. First 3 results:

Primary Tumor Characteristics Are Important Prognostic Factors for Sorafenib-Treated Patients with Metastatic Renal Cell Carcinoma: A Retrospective Multicenter Study.
 

Author(s): Sung Han Kim, Sohee Kim, Byung-Ho Nam, Sang Eun Lee, Choung-Soo Kim, Ill Young Seo, Tae Nam Kim, Sung-Hoo Hong, Tae Gyun Kwon, Seong Il Seo, Kwan Joong Joo, Kanghyon Song, Cheol Kwak, Jinsoo Chung

Journal: Biomed Res Int. 2017 ;2017():9215930.

 

We aimed to identify prognostic factors associated with progression-free survival (PFS) and overall survival (OS) in metastatic renal cell carcinoma (mRCC) patients treated with sorafenib. We investigated 177 patients, including 116 who received sorafenib as first-line therapy, using ...

Last Updated: 8 Mar 2017

Go To URL
Adjuvant Sunitinib in Renal-Cell Carcinoma.
 

Author(s): Alain Ravaud

Journal: N. Engl. J. Med.. 2017 03;376(9):893.

 

Last Updated: 1 Mar 2017

Go To URL
Hereditary leiomyomatosis and renal cell cancer syndrome associated renal cell carcinoma.
 

Author(s): Shraddha Adamane, Sangeeta Desai, Santosh Menon

Journal: Indian J Pathol Microbiol. ;60(1):108-110.

 

Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is a recently described entity with unknown exact prevalence. The affected individuals are predisposed to have multiple leiomyomas and renal cancer due to germline mutation in fumarate hydratase gene on chromosome 1. The knowledge ...

Last Updated: 14 Feb 2017

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Renal cell carcinoma" returned 523 free, full-text review articles on human participants. First 3 results:

Clinical and Prognostic Effect of Plasma Fibrinogen in Renal Cell Carcinoma: A Meta-Analysis.
 

Author(s): Yuejun Tian, Mei Hong, Suoshi Jing, Xingchen Liu, Hanzhang Wang, Xinping Wang, Dharam Kaushik, Ronald Rodriguez, Zhiping Wang

Journal: Biomed Res Int. 2017 ;2017():9591506.

 

Background. Although numerous studies have shown that plasma fibrinogen is linked to renal cell carcinoma (RCC) risk, the consistency and magnitude of the effect of plasma fibrinogen are unclear. The aim of the study was to explore the association between plasma fibrinogen and RCC ...

Last Updated: 3 Feb 2017

Go To URL
Targeted Therapy for Metastatic Renal Cell Carcinoma.
 

Author(s): Andika Afriansyah, Agus Rizal Ah Hamid, Chaidir A Mochtar, Rainy Umbas

Journal: Acta Med Indones. 2016 Oct;48(4):335-347.

 

In the past 10 years, recent development of targeted therapy in metastatic renal cell carcinoma (mRCC) has provided a new hope and significantly enhanced the prognosis of the disease. Three class of targeted therapy were developed, including multi-targeted tyrosine kinase inhibitors ...

Last Updated: 1 Feb 2017

Go To URL
Clinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studies.
 

Author(s): Xiangming Cheng, Weidong Gan, Gutian Zhang, Xiaogong Li, Hongqian Guo

Journal:

 

Renal cell carcinoma (RCC) associated with Xp11.2 translocation/TFE3 gene fusion (Xp11.2 RCC) is a rare subtype of RCC which is firstly described as a distinct entity in 2004 so that clinical characteristics of Xp11.2 RCC in different gender and age are unknown. The purpose of systematic ...

Last Updated: 12 Jul 2016

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
 

Status: Recruiting

Condition Summary: Renal Cell Carcinoma

 

Last Updated: 26 Oct 2016

Go to URL
Molecular Determinants for Therapy Response on Renal Cell Carcinoma
 

Status: Recruiting

Condition Summary: Renal Cell Carcinoma

 

Last Updated: 31 Jul 2014

Go to URL
Post Marketing Surveillance for PROSENSE™ a Cryotherapy Treatment of Renal Cell Carcinoma
 

Status: Recruiting

Condition Summary: Renal Cell Carcinoma

 

Last Updated: 17 Feb 2017

Go to URL